Model DGH 6000 Scanmate A
510(k) K093371
Active
Valid until
No date given
FDA recalls
None foundTrust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE 510(k) | NumberK093371 | Date5 Apr 2010 | StatusActive |
| European Union | CE/MDD EUDAMED | Number— | Date— | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
- European Union
- United States
Specification
- 510(k) Number
- FDA product code
- IYO
- FDA applicant
- Dgh Technology, Inc.
- Device class
- Class II
- Regulation
- 21 CFR Part 892.1560
- Advisory committee
- Radiology
- FDA decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 18 Sep 2026
The Model DGH 6000 Scanmate A is an A-scan ultrasound biometry device designed for ocular measurements. It provides real-time axial length, anterior chamber depth, and lens thickness assessments, enabling precise intraocular lens (IOL) power calculations for cataract surgery planning.
This portable device is intended for use in clinical ophthalmology settings and is supplied as a reusable instrument. It has received FDA 510(k) clearance under the Radiology advisory committee and complies with the Medical Device Directive (MDD). Sterility and MRI safety specifications are not indicated in the available data.
Other devices from Dgh Technology Inc.
Questions
AI-generated answers, 18 Sep 2026
What clinical measurements does the Model DGH 6000 Scanmate A provide, and how are they used in cataract surgery planning?
The Model DGH 6000 Scanmate A performs real-time A-scan ultrasound biometry, measuring axial length, anterior chamber depth, and lens thickness. These metrics are critical for calculating the precise power of intraocular lenses (IOLs) during cataract surgery planning, ensuring accurate lens placement and patient outcomes.
Is the Model DGH 6000 Scanmate A designed for single-use or reusable clinical settings, and what maintenance considerations should be noted?
The device is explicitly supplied as a reusable instrument, meaning it is intended for repeated use in clinical ophthalmology settings. Since it is not sterile by default, proper cleaning and maintenance protocols must be followed to ensure reliability and patient safety between uses.
How portable is the Model DGH 6000 Scanmate A, and what type of clinical environments is it intended for?
The device is described as portable, making it suitable for use in various clinical ophthalmology settings, including outpatient clinics, surgical centers, or mobile eye care units where space or flexibility is a consideration.
What regulatory pathways does the Model DGH 6000 Scanmate A follow, and which advisory committee was involved in its FDA clearance?
The device received FDA 510(k) clearance under the Radiology advisory committee (RA), with a decision dated April 5, 2010. It was also compliant with the Medical Device Directive (MDD). The clearance was granted as substantially equivalent (SESE) to a predicate device, following a traditional review process.